Construction of mutation burden estimation model for predicting efficacy of cancer immunotherapy
碩士 === 國立陽明大學 === 生物醫學資訊研究所 === 105 === Abstract Cancer is the leading cause of human death worldwide. Many researches are dedicated to finding the therapeutics of the disease, and immunotherapy is one of the new therapeutic approaches. The most popular drugs of immunotherapy is the immune checkpoin...
Main Authors: | Guan-Yi Lyu, 呂冠毅 |
---|---|
Other Authors: | Yu-Chao Wang |
Format: | Others |
Language: | en_US |
Published: |
2017
|
Online Access: | http://ndltd.ncl.edu.tw/handle/83795893168676353125 |
Similar Items
-
Predictive Value of Tumor Mutation Burden in Immunotherapy for Lung Cancer
by: Huanlan SA, et al.
Published: (2019-06-01) -
Mutation load estimation model as a predictor of the response to cancer immunotherapy
by: Guan-Yi Lyu, et al.
Published: (2018-04-01) -
High tumor mutation burden predicts better efficacy of immunotherapy: a pooled analysis of 103078 cancer patients
by: Dedong Cao, et al.
Published: (2019-09-01) -
MUC4, MUC16, and TTN genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer
by: Yue Yang, et al.
Published: (2020-08-01) -
Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy
by: Timothy V. Pham, et al.
Published: (2020-08-01)